AI Product

Lunit — Medical Imaging

AI-powered cancer diagnostics spanning chest X-ray, mammography, digital breast tomosynthesis, and pathology biomarker products (Lunit INSIGHT, Lunit SCOPE), plus therapeutics-oriented…

Intelligence Summary

Product
  • Active
  • Verified public sources
  • Developer Lunit
  • Category Medical Imaging
  • Status Active
  • Latest update 2013: Lunit founded in Seoul (originally as CLDI, pivoting to medical imaging).
  • Documentation Official page
  • Last reviewed Jul 2026
5 Technologies

Official product page

Target customer

Hospitals, screening programs, imaging networks, and biopharmaceutical partners seeking FDA- or CE-cleared AI augmentation for oncology workflows.

Features & capabilities

Industries: AI in Healthcare; Medical Imaging

Related reports

Related insights

Overview

AI-powered cancer diagnostics spanning chest X-ray, mammography, digital breast tomosynthesis, and pathology biomarker products (Lunit INSIGHT, Lunit SCOPE), plus therapeutics-oriented offerings.

Product and company

Lunit — Medical Imaging is a verified product offering linked to the Brel Digital company profile for Lunit.

Use cases

AI-powered cancer diagnostics spanning chest X-ray, mammography, digital breast tomosynthesis, and pathology biomarker products (Lunit INSIGHT, Lunit SCOPE), plus therapeutics-oriented offerings.

Target customer

Hospitals, screening programs, imaging networks, and biopharmaceutical partners seeking FDA- or CE-cleared AI augmentation for oncology workflows.

Technologies

Primary technologies assigned from the linked company profile: Deep Learning, Healthcare Analytics, Machine Learning, Medical Imaging, Predictive Analytics.

Sources and references

  • Official product / company source: https://www.lunit.io/en/media-hub/lunit-completes-acquisition-of-volpara-pioneering-next-level-of-ai-driven-cancer-care/
  • Supporting source: https://www.lunit.io/en/about/

Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.

Last reviewed

This product profile was last reviewed on 2026-07-14.

Correction request

If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.

Features and capabilities

  • AI-powered cancer diagnostics spanning chest X-ray, mammography, digital breast tomosynthesis, and pathology biomarker products (Lunit INSIGHT, Lunit SCOPE), plus therapeutics-oriented offerings.

Extracted from the linked company product description already verified on Brel. No capabilities were invented.

Sources and references

This article draws on publicly available company information, official websites, filings, interviews, announcements, and other cited sources. Information may change over time.

Enquire about this product profile

Messages are delivered to contact@breldigital.com.